DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

1.79 0.05 (2.87%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NAVB $1.79 2.87%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.73
Previous Close $1.74
Daily Range $1.72 - $1.88
52-Week Range $0.97 - $2.25
Market Cap $269.8M
P/E Ratio -6.00
Dividend (Yield) $0.00 (0.0%)
Volume 2,449,006
Average Daily Volume 1,675,279
Current FY EPS -$0.21

Sector

Healthcare

Industry

Healthcare Information Services

Navidea Biopharmaceuticals, Inc. (NAVB) Description

Neoprobe Corporation is a biomedical company which is engaged in the development and commercialization of innovative surgical and diagnostic products that enhance patient care by meeting the critical decision making needs of physicians. Website: http://www.navidea.com/

News & Commentary Rss Feed

This Week in Biotech: Actions Speak Louder Than Words

Regulatory actions provided the impetus to big moves for these five biotech stocks.

Can the Rally in Navidea (NAVB) Shares Continue? - Tale of the Tape

Macrophage Therapy Is Navidea's Value Driver

European Commission Approves Navidea's Sentinel Lymph Node Detection Agent Lymphoseek

Navidea Biopharmaceuticals (NAVB) Jumps: Stock Up 7.8% - Tale of the Tape

Sector Update: Health Care Stocks Generally Higher Pre-Bell

Sector Update: Health Care

Navidea Receives $1.1M PDUFA Filing Fee Refund For Award Of Orphan Drug Status; Platinum Partners Re

Navidea Receives $1.1M PDUFA Filing Fee Refund For Award Of Orphan Drug Status; Platinum Partners Reaffirms Commitment To Line Of Credit

Navidea Biopharmaceuticals, Inc's (NAVB) CEO Rick Gonzalez on Q3 2014 Results - Earnings Call Transc

Navidea Biopharmaceuticals, Inc's (NAVB) CEO Rick Gonzalez on Q3 2014 Results - Earnings Call Transcript

Navidea Biopharmaceuticals Q3: What's Going On With Lymphoseek?

Navidea Biopharmaceuticals (NAVB) Q3 2014 Results - Earnings Call Webcast

See More NAVB News...

NAVB's Top Competitors

NAVB $1.79 (2.87%)
Current stock: NAVB
$0.00 (0.00%)
Current stock:
MDT $74.62 (-0.01%)
Current stock: MDT
COV $102.90 (-0.31%)
Current stock: COV